Expression and purification of soluble HIV-1 envelope glycoprotein gp160 mutant from Saccharomyces cerevisiae(GENETICS, MOLECULAR BIOLOGY AND GENE ENGINEERING)
スポンサーリンク
概要
- 論文の詳細を見る
Here we report the expression of HIV-1 gp160 and its mutated proteins in Saccharomyces cerevisiae. Two strong hydrophobic regions, aa 511-537 and aa 679-703, were predicted by GCG Wisconsin Package software and removed to investigate the solubility of the mutated gp160 (gp160Δ12). The results showed that gp160Δ12 assumes high solubility as to be present in supernatant of cell lysate exclusively. The mutant exists as trimeric form in solutions via some inter-molecule disulfide bonds, which can be associated to monomer with the reduced reaction of DTT. The fermentation procedure was optimized to get high cell density yield and expression level as 〜10mg/L. After purification with electro elution, gp160Δ12 was checked as glycosylation form by Endo-H deglycosylating catalysis. The ELISA performed with a panel of human sera suggests that the purified gp160Δ12 shares some determinants with gp120 and gp41, but exposes some distinct epitopes that react with early HIV-infected antibody. Thus, we may provide a novel antigen for immunodetection assay, vaccine candidate, and other relative research purposes.
- 公益社団法人日本生物工学会の論文
著者
-
ZHANG Jun
National Institute of Diagnostics and Vaccine Development in infectious disease, The Key Laboratory
-
Yang Chunyan
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
Yang Kunyu
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
Li Shaowei
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
He Fangping
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
Zhang Jiannan
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
Wei Minxi
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
Pan Huirong
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
Xiong Junhui
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
Xia Ningshao
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Scie
-
Yang Kunyu
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
Li Shaowei
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
He Fangping
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
Pan Huirong
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
Xia Ningshao
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
Xiong Junhui
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
Zhang Jiannan
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Scien
-
Wei Minxi
National Institute Of Diagnostics And Vaccine Development In Infectious Disease School Of Life Sciences Xiamen University:key Laboratory Of The Ministry Of Education For Cell Biology And Tumor Cell Engineering School Of Life Science Xiamen University
関連論文
- Variants of Green Fluorescent Protein GFPxm
- Expression and purification of soluble HIV-1 envelope glycoprotein gp160 mutant from Saccharomyces cerevisiae(GENETICS, MOLECULAR BIOLOGY AND GENE ENGINEERING)
- Adaptive Cooperation Switching for Multicell Downlink Using Statistical CSI
- Maximizing Antibody Production in Suspension-Cultured Mammalian Cells by the Customized Transient Gene Expression Method
- Adaptive Cooperation Switching for Multicell Downlink Using Statistical CSI
- Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy